ERBB2 and cancer: In another study, a QD-based two-color quantitative in situ imaging technique was used to investigate the co-expression of Ki67 (stained as a distinct red fluorescence in the nucleus of the cancer cell) and HER2 (stained as a bright green fluorescence on the cell membrane) and to determine the individual impact of these molecules on prognosis.